Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Aug;95(2):222-42.
doi: 10.1016/j.critrevonc.2015.03.002. Epub 2015 Mar 14.

Chronic myelomonocytic leukemia: Forefront of the field in 2015

Christopher B Benton  1 , Aziz Nazha  2 , Naveen Pemmaraju  3 , Guillermo Garcia-Manero  4
Affiliations
Review

Chronic myelomonocytic leukemia: Forefront of the field in 2015

Christopher B Benton et al. Crit Rev Oncol Hematol. 2015 Aug.

Abstract

Chronic myelomonocytic leukemia (CMML) includes components of both myelodysplastic syndrome and myeloproliferative neoplasms and is associated with a characteristic peripheral monocytosis. CMML is caused by the proliferation of an abnormal hematopoietic stem cell clone and may be influenced by microenvironmental changes. The disease is rare and has undergone revisions in its classification. We review the recent classification strategies as well as diagnostic criteria, focusing on CMML's genetic alterations and unique pathophysiology. We also discuss the latest molecular characterization of the disease, including how molecular factors affect current prognostic models. Finally, we focus on available treatment strategies, with a special emphasis on experimental and forthcoming therapies.

Keywords: Chronic myelomonocytic leukemia; Myelodysplastic syndrome; Myeloproliferative neoplasms.

PubMed Disclaimer

References

    1. Foucar K. Myelodysplastic/myeloproliferative neoplasms. American journal of clinical pathology. 2009;132:281–9. - PubMed
    1. Saarni MI, Linman JW. Myelomonocytic leukemia: disorderly proliferation of all marrow cells. Cancer. 1971;27:1221–30. - PubMed
    1. Vardiman JW, Harris NL, Brunning RD. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood. 2002;100:2292–302. - PubMed
    1. Zittoun R, Bernadou A, Bilski-Pasquier G, Bousser J. Subacute myelo-monocytic leukemia. Study of 27 cases and review of the literature. La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris. 1972;48:1943–56. - PubMed
    1. Germing U, Gattermann N, Strupp C, Aivado M, Aul C. Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients. Leukemia research. 2000;24:983–92. - PubMed

MeSH terms